For years, scientists have hoped to harness the immune system to attack cancer using a group of drugs known as CD40 agonist ...

Several oncology companies announced key trial milestones this week across the landscape of both blood cancers and solid ...

VU grad wins Fulbright grant Micah Koppang, a 2025 Valparaiso University graduate, has been selected for a Fulbright scholarship. Koppang, a Spanish major with a minor in political science who ...

SHELTON, CONNECTICUT / ACCESS Newswire / August 18, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC ...

Synthetic generation replicates key clinical patterns from real-world data, enabling valid analyses with fewer patients.

The ALS therapy ATH-1105 entered the brain and spinal cord at dose-proportional levels in healthy volunteers, and had a good ...

Iran – A new randomized clinical trial published in Dermatologic Therapy has found that intramuscular pantothenic acid ...

Private equity firm THL Partners has agreed to buy a majority stake in Headlands Research, a U.S.-based network of clinical ...